Your browser doesn't support javascript.
loading
Multiplex immunohistochemistry/immunofluorescence (mIHC/IF) for PD-L1 testing in triple-negative breast cancer: a translational assay compared with conventional IHC.
Yeong, Joe; Tan, Tira; Chow, Zi Long; Cheng, Qing; Lee, Bernett; Seet, Amanda; Lim, Johnathan Xiande; Lim, Jeffrey Chun Tatt; Ong, Clara Chong Hui; Thike, Aye Aye; Saraf, Sahil; Tan, Benjamin Yong Cheng; Poh, Yong Cheng; Yee, Sidney; Liu, Jin; Lim, Elaine; Iqbal, Jabed; Dent, Rebecca; Tan, Puay Hoon.
Afiliación
  • Yeong J; Division of Pathology, Singapore General Hospital, Singapore joe.yeong.p.s@sgh.com.sg tan.puay.hoon@singhealth.com.sg.
  • Tan T; Integrative Biology for Theranostics, Institute of Molecular Cell Biology, Agency of Science, Technology and Research (A*STAR), Singapore.
  • Chow ZL; Singapore Immunology Network (SIgN), Agency of Science, Technology and Research (A*STAR), Singapore.
  • Cheng Q; Division of Medical Oncology, National Cancer Centre Singapore, Singapore.
  • Lee B; Division of Pathology, Singapore General Hospital, Singapore.
  • Seet A; University of Tasmania, Hobart, Tasmania, Australia.
  • Lim JX; Duke-NUS Medical School, Duke-NUS Medical School, Singapore.
  • Lim JCT; Singapore Immunology Network (SIgN), Agency of Science, Technology and Research (A*STAR), Singapore.
  • Ong CCH; Division of Medical Oncology, National Cancer Centre Singapore, Singapore.
  • Thike AA; Division of Pathology, Singapore General Hospital, Singapore.
  • Saraf S; Integrative Biology for Theranostics, Institute of Molecular Cell Biology, Agency of Science, Technology and Research (A*STAR), Singapore.
  • Tan BYC; Division of Pathology, Singapore General Hospital, Singapore.
  • Poh YC; Department of Anatomical Pathology, Singapore General Hospital, Singapore.
  • Yee S; Division of Pathology, Singapore General Hospital, Singapore.
  • Liu J; Division of Pathology, Singapore General Hospital, Singapore.
  • Lim E; Division of Pathology, Singapore General Hospital, Singapore.
  • Iqbal J; Diagnostics Development (DxD) Hub, Agency of Science, Technology and Research (A*STAR), Singapore.
  • Dent R; Diagnostics Development (DxD) Hub, Agency of Science, Technology and Research (A*STAR), Singapore.
  • Tan PH; Duke-NUS Medical School, Duke-NUS Medical School, Singapore.
J Clin Pathol ; 73(9): 557-562, 2020 Sep.
Article en En | MEDLINE | ID: mdl-31969377
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Biomarcadores de Tumor / Carcinoma de Pulmón de Células no Pequeñas / Antígeno B7-H1 / Neoplasias de la Mama Triple Negativas / Neoplasias Pulmonares / Anticuerpos Monoclonales Tipo de estudio: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Female / Humans País/Región como asunto: Asia Idioma: En Revista: J Clin Pathol Año: 2020 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Biomarcadores de Tumor / Carcinoma de Pulmón de Células no Pequeñas / Antígeno B7-H1 / Neoplasias de la Mama Triple Negativas / Neoplasias Pulmonares / Anticuerpos Monoclonales Tipo de estudio: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Female / Humans País/Región como asunto: Asia Idioma: En Revista: J Clin Pathol Año: 2020 Tipo del documento: Article